Toast, Inc. <TOST.N>: Needham raises target price to $45 from $35
TOST•Related News
Propanc Biopharma files draft information statement on restricted stock issuances
PPCB•
Hinge Health, Inc. <HNGE.N>: Barclays Raises Target Price to $100 From $97
HNGE•
Natera seeks Japan PMDA approval for Signatera test in muscle-invasive bladder cancer
NTRA•
The US box office is booming, but fewer people are going to the movies
AMC•
Certara: Barclays raises target price to $7.5 from $6.5
CERT•